ATI RN
Adult Health Nursing Test Bank Questions
Question 1 of 5
A patient that had a stroke is experiencing memory loss and impaired learning capacity. In which lobe does the nurse determine that brain damage has MOST likely occurred?
Correct Answer: D
Rationale: The correct answer is D: Temporal lobe. Memory and learning are primarily associated with the temporal lobe, specifically the hippocampus. Damage to this area due to stroke can lead to memory loss and impaired learning capacity. Frontal lobe (A) is involved in decision-making and problem-solving. Parietal lobe (B) is responsible for sensory processing. Occipital lobe (C) is related to visual processing. Therefore, the temporal lobe is the most likely site of brain damage in this scenario based on the symptoms presented.
Question 2 of 5
Select the medication that should be discussed by the nurse with the attending physician before administering it to patient with acute angle closure glaucoma
Correct Answer: D
Rationale: The correct answer is D: Atropine. Atropine is a mydriatic agent that can exacerbate acute angle closure glaucoma by dilating the pupil and potentially worsening the condition. The nurse should discuss with the attending physician before administering it to avoid worsening the patient's condition. A: Isopto carpine eye drops are actually used in the treatment of acute angle closure glaucoma as they help in lowering intraocular pressure, so there is no need to discuss this with the physician. B: Mannitol is used as an osmotic diuretic to reduce intraocular pressure in acute angle closure glaucoma, and it does not directly affect the pupil, so it does not require discussion with the physician before administration. C: Corticosporin ophthalmic is a combination of an antibiotic and a corticosteroid used to treat eye infections and inflammation, but it does not have a direct effect on worsening acute angle closure glaucoma, so it does
Question 3 of 5
A patient presents with muscle weakness and fatigue. Upon further examination, it is revealed that the patient has decreased acetylcholine receptors at the neuromuscular junction. Which of the following conditions is most likely responsible for this presentation?
Correct Answer: A
Rationale: The correct answer is A: Myasthenia gravis. In myasthenia gravis, there is a decrease in acetylcholine receptors at the neuromuscular junction, leading to muscle weakness and fatigue. This occurs due to autoimmune destruction of these receptors. ALS (B) affects motor neurons, not acetylcholine receptors. Guillain-Barre syndrome (C) is an autoimmune disorder affecting peripheral nerves, not neuromuscular junctions. Muscular dystrophy (D) is a genetic disorder causing muscle degeneration, not affecting acetylcholine receptors.
Question 4 of 5
A patient with a history of congestive heart failure is prescribed furosemide. Which electrolyte imbalance is the patient at risk for developing with furosemide therapy?
Correct Answer: B
Rationale: Step 1: Furosemide is a loop diuretic that works in the ascending loop of Henle to inhibit sodium and chloride reabsorption. Step 2: Inhibition of sodium reabsorption leads to increased water and electrolyte excretion, including potassium. Step 3: Increased potassium excretion can lead to hypokalemia, which is a common side effect of loop diuretics like furosemide. Step 4: Hypokalemia can be dangerous, especially in patients with congestive heart failure, as it can worsen cardiac function and lead to arrhythmias. Step 5: Therefore, patients with a history of congestive heart failure prescribed furosemide are at risk for developing hypokalemia due to increased potassium excretion.
Question 5 of 5
A patient with a history of asthma is prescribed an inhaled corticosteroid. Which adverse effect is associated with long-term use of inhaled corticosteroids?
Correct Answer: D
Rationale: The correct answer is D: Osteoporosis. Long-term use of inhaled corticosteroids can lead to decreased bone density and an increased risk of osteoporosis. Corticosteroids can interfere with calcium absorption and bone formation, resulting in bone weakening. Oral thrush (Choice A) is a common side effect of inhaled corticosteroids, but it is not associated with long-term use. Hypertension (Choice B) and hyperglycemia (Choice C) are more commonly seen with systemic corticosteroid use rather than inhaled corticosteroids.